David Windley Analyst PerformanceAnalyst at UBS GroupDavid Windley is a stock analyst at UBS Group focused in the healthcare sector, covering 20 publicly traded companies. Over the past year, David Windley has issued 34 stock ratings, including buy and hold recommendations. While full access to David Windley's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Windley's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings83 Last 11 YearsBuy Recommendations69.88% 58 Buy RatingsCompanies Covered20 Unique Companies Ratings Distribution83RatingsDistribution of strong buy, buy, hold, and sell ratings by David Windley.RatingPercentageCount Strong Buy0.0%0 ratings Buy69.9%58 ratings Hold30.1%25 ratings Sell0.0%0 ratingsOut of 83 total stock ratings issued by David Windley at UBS Group, the majority (69.9%) have been Buy recommendations, followed by 30.1% Hold.Best & Worst CallsBest Call0000.0%CRLSep 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%MOHJul 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE70.0% of companies on NYSE14 companiesNASDAQ25.0% of companies on NASDAQ5 companiesOTCMKTS5.0% of companies on OTCMKTS1 companyDavid Windley, an analyst at UBS Group, currently covers 20 companies listed on NYSE, NASDAQ and OTCMKTS, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageHealthcare17 companies85.0%Consumer Staples1 company5.0%Finance1 company5.0%Miscellaneous1 company5.0%David Windley of UBS Group specializes in stock coverage within the Healthcare sector, with additional focus on Consumer Staples and Finance companies.Coverage IndustriesIndustryPercentageHEALTHCARE PROVIDERS & SERVICES7 companies35.0%LIFE SCIENCES TOOLS & SERVICES5 companies25.0%HEALTHCARE TECHNOLOGY3 companies15.0%HEALTHCARE EQUIPMENT & SUPPLIES2 companies10.0%BEVERAGES1 company5.0%INSURANCE1 company5.0%Miscellaneous1 company5.0% David Windley's Ratings History at UBS Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCICigna Group11/12/2026Boost Price Target$296.49$304.00Hold$0.0000.00% ROICERTCertara11/6/2026Reiterated Rating$12.07$12.00Hold$0.0000.00% ROIHUMHumana11/6/2026Reiterated Rating$424.31$420.00Buy$0.0000.00% ROIVEEVVeeva Systems11/6/2026Boost Price Target$304.23$375.00Buy$0.0000.00% ROIWSTWest Pharmaceutical Services11/2/2026Reiterated Rating$412.73$475.00Buy$0.0000.00% ROIFTREFortrea10/30/2026Reiterated Rating$23.14$21.50Hold$0.0000.00% ROICNCCentene10/29/2026Reiterated Rating$67.11$69.00Hold$0.0000.00% ROIICLRIcon10/29/2026Reiterated Rating$214.16$254.00Buy$0.0000.00% ROIMOHMolina Healthcare10/23/2026Reiterated Rating$216.55$220.00Hold$0.0000.00% ROICRLCharles River Laboratories International9/28/2026Boost Price Target$292.49$340.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. MEDPMedpace9/14/2026Reiterated Rating$587.52Hold$0.0000.00% ROICICigna Group8/4/2026Downgrade$282.27$307.00Hold$0.0000.00% ROICICigna Group8/4/2026Downgrade$282.27$307.00Hold$0.0000.00% ROIUNHUnitedHealth Group7/17/2026Boost Price Target$371.80$490.00Buy$0.0000.00% ROIMEDPMedpace7/7/2026Downgrade$565.09$515.00Hold$0.0000.00% ROICNCCentene4/29/2026Boost Price Target$49.42$48.00Hold$0.0000.00% ROIELVElevance Health4/20/2026Lower Price Target$323.02$391.00Buy$0.0000.00% ROICICigna Group4/20/2026Lower Price Target$278.29$330.00Buy$0.0000.00% ROICNCCentene4/20/2026Reiterated Rating$38.11$39.00Hold$0.0000.00% ROIOSCROscar Health4/20/2026Upgrade$15.78$16.00Hold$0.0000.00% ROIUNHUnitedHealth Group4/20/2026Boost Price Target$323.62$373.00Buy$0.0000.00% ROIICLRIcon2/23/2026Upgrade$99.70$135.00Buy$0.0000.00% ROIICLRIcon2/23/2026Upgrade$104.66$135.00Buy$0.0000.00% ROIMEDPMedpace2/13/2026Upgrade$416.04$560.00Buy$0.0000.00% ROIHUMHumana2/12/2026Lower Price Target$180.49$235.00Buy$0.0000.00% ROIWSTWest Pharmaceutical Services2/10/2026Reiterated Rating$250.33$295.00Buy$0.0000.00% ROICICigna Group2/9/2026Boost Price Target$294.00$333.00Buy$0.0000.00% ROIIQVIQVIA2/6/2026Lower Price Target$187.48$255.00Buy$0.0000.00% ROIUNHUnitedHealth Group1/28/2026Lower Price Target$294.00$340.00Buy$0.0000.00% ROIHUMHumana1/26/2026Lower Price Target$196.00$310.00Buy$0.0000.00% ROIHUMHumana12/5/2025Upgrade$252.84$313.00Buy$0.0000.00% ROIDEODiageo12/3/2025Reiterated Rating$92.03Neutral$0.0000.00% ROIVEEVVeeva Systems11/24/2025Reiterated Rating$243.98$330.00Buy$0.0000.00% ROICICigna Group11/3/2025Reiterated Rating$244.67$310.00Buy$000.0000.00% ROIUNHUnitedHealth Group10/17/2025Boost Price Target$357.39$409.00Buy$000.0000.00% ROICRLCharles River Laboratories International9/9/2025Upgrade$161.97$195.00Buy$000.0000.00% ROIIQVIQVIA9/9/2025Upgrade$187.72$225.00Buy$000.0000.00% ROIICLRIcon9/9/2025Downgrade$177.81$175.00Hold$000.0000.00% ROIMEDPMedpace9/9/2025Boost Price Target$492.09$450.00Hold$000.0000.00% ROIFTREFortrea9/9/2025Boost Price Target$10.32$9.50Hold$00.0000.00% ROIToday's free pick (on me) (Ad)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.Get today's free pick before December 8th.STESTERIS5/29/2025Initiated Coverage$245.03$263.00Hold$000.0000.00% ROISLQTSelectQuote5/21/2025Initiated Coverage$2.26$2.75Hold$0.0000.00% ROICNCCentene4/29/2025Lower Price Target$59.23$61.00Hold$00.0000.00% ROICNCCentene4/8/2025Upgrade$61.27$64.00Hold$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche BankBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
